Literature DB >> 20432529

Rheumatoid arthritis: a new challenge in coming era.

Prarthana V Rewatkar1, Ganesh R Kokil, Arunima Verma, Suresh Thareja.   

Abstract

Rheumatoid arthritis (RA) is mainly an auto-immune disease characterized by inflammation in joints. 1 in 50 people develop RA at some stage and at any age. This review summarizes the etiology, pathophysiology, risk factor, and treatment related to RA. The emphasis has been laid in particular on the new potential biological targets and the possible treatment as well as the current ongoing research status on RA.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20432529     DOI： 10.2174/138955710791185136

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN： 1389-5575            Impact factor:   3.862


  3 in total

1.  Anti-inflammatory and Anti-arthritic Effects of a Novel Leflunomide Analogue, UTL-5b (GBL-5b).

Authors:  Jiajiu Shaw; Ben Chen; Paul Wooley; Wen-Hsin Huang; An-Rong Lee; Dustin Zeng
Journal:  Am J Biomed Sci       Date:  2011-01-01

2.  C-Reactive Protein Promotes the Activation of Fibroblast-Like Synoviocytes From Patients With Rheumatoid Arthritis.

Authors:  Zhengyu Fang; Jiyang Lv; Jing Wang; Qingxia Qin; Juan He; Meiying Wang; Gengmin Zhou; Guoyu Liu; Fubo Zhong; Yadan Zheng; Hui-Yao Lan; Qingwen Wang
Journal:  Front Immunol       Date:  2020-05-20       Impact factor: 7.561

3.  Local gene transfer of OPG prevents joint damage and disease progression in collagen-induced arthritis.

Authors:  Qingguo Zhang; Weiming Gong; Bin Ning; Lin Nie; Paul H Wooley; Shang-You Yang
Journal:  ScientificWorldJournal       Date:  2013-10-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.